FDA's Actions Threaten American Health: The Agency Itself

Jun.30.2022
FDA threatens American health with battery, banning effective smoking cessation tool, electronic cigarettes, and proposing new regulations.

The FDA poses a deadly threat to the health of Americans - the very organization that is meant to protect them. Despite a significant decrease in smoking rates over the past decade, bureaucratic efforts aimed at building the FDA empire are now working to reverse this trend.


The US Food and Drug Administration (FDA) has ordered Juul, a popular electronic cigarette manufacturer, to cease sales of its products. Juul has been widely regarded as the most effective product designed to help smokers quit their addiction to cigarettes. The FDA has also proposed limiting nicotine levels in traditional cigarettes – a method that has proven ineffective in the past, leading smokers to obtaining nicotine through more dangerous means, such as smoking more cigarettes or purchasing high-strength tobacco products on the black market.


A federal judge has suspended the ban on Juul products, which was implemented in response to concerns about their impact on public health. The move has been criticized for going against both public health principles and political wisdom; why would millions of voters be deprived of e-cigarettes in an election year? According to the FDA, it has been unable to identify any direct dangers posed by Juul products to the public. The FDA also claims that Juul has not provided sufficient safety information, but this assertion is questionable given that the company spent over $100 million on its application to the FDA. Moreover, focusing on the slight unknown risks of e-cigarettes is foolish; UK public health authorities estimate that e-cigarettes are 95% less harmful than traditional cigarettes.


The ban only makes sense to bureaucrats and special interests who perceive an e-cigarette threat. E-cigarettes offer many benefits of nicotine - weight control, improved attention and cognitive performance, reduced anxiety, and enhanced mood - without the thousands of toxins found in traditional cigarettes. Like caffeine, nicotine can be habit-forming and can cause a temporary, mild increase in blood pressure. As summarized by the Royal Society for Public Health, both are "fairly harmless.


Anti-e-cigarette activists and their supporters at the FDA claim that e-cigarettes are a gateway for youth smoking, but in the age of e-cigarettes, the rate of youth smoking has decreased much faster than in previous years. Ten years ago, when e-cigarettes were introduced, 13% of high school students smoked; today, that number is less than 2%.


No one wants to see teenagers become addicted to nicotine, but purchasing e-cigarettes is already illegal. Research indicates that in the past two years, the rate of e-cigarette use among high school students has sharply declined. Moreover, most e-cigarette users in this age group only use the devices occasionally, and typically not with nicotine. (Most of them report using e-cigarettes to inhale marijuana, but the FDA has not banned the sale of marijuana to adults on this basis.)


In the era of vaping, smoking rates among adults have sharply declined, particularly since the introduction of Juul, with obvious benefits for health. A recent study tracked over 30,000 Americans for six years and found that e-cigarette users had a one-third lower incidence of cardiovascular disease compared to smokers, with no difference in incidence compared to those who neither smoke cigarettes nor use e-cigarettes.


Other studies suggest that electronic cigarettes are more effective than other nicotine replacement therapies, such as nicotine patches or gum, in helping smokers quit. Even smokers who do not intend to quit can increase their chances of quitting if they use an e-cigarette at least once a day. Juul has been particularly successful because it provides a high dose of nicotine in a fast-absorbing form, similar to tobacco cigarettes. One study found that 50% of Juul users quit smoking within a year, while another shows that smokers who use the full-strength Juul, rather than the lower nicotine content version, are more likely to quit.


This is good news for public health, but bad news for companies that market smoking cessation products with low efficiency, as well as activists, scholars, and bureaucrats dedicated to anti-smoking efforts. With so many Americans using electronic cigarettes to quit smoking, how can anti-smoking activists justify their work? There is also a significant financial component: the US Food and Drug Administration annually collects more than $800 million from tobacco use fees, which should be aimed at reducing the harm of tobacco products to improve health.


In order to maintain a steady flow of funding, bureaucrats have misguidedly labeled electronic cigarettes as "tobacco products" and set new goals to eliminate nicotine. Since the start of the anti-vaping movement, the FDA’s Center for Tobacco Products has more than doubled its staff to over 1,100 employees, distributing billions of dollars in external grants each year, with a significant portion going towards non-profit organizations spreading anti-vaping messages and researchers advocating for nicotine bans.


Unfortunately, with the help of mainstream journalists, the FDA's misguided campaign has been successful. They have blamed deaths on electronic cigarettes to be caused by black-market THC products, creating a moral panic. In the early days of the e-cigarette era, most Americans saw them as a safer alternative to tobacco cigarettes. However, subsequent investigations led many to believe that e-cigarettes were just as dangerous, if not more so. This erroneous belief could lead many smokers to shorter lifespans.


Banning nicotine is an unrealistic and pointless goal. The issue of teenage smoking pales in comparison to alcohol abuse, but we know that prohibiting the sale of alcohol to adults would create more problems than it solves. This holds true for electronic cigarettes as well. If the FDA successfully bans products like Juul, Americans will only return to smoking or turn to the black market for less safe e-cigarette devices.


According to Michael Siegel, a researcher in tobacco control at Tufts University, "At least four million smokers have successfully quit smoking by using e-cigarettes and still rely on these products to stay away from cigarettes." He has been studying tobacco control for thirty years. "If the FDA doesn't approve most e-cigarettes, the ultimate result will be a public health tragedy, with a large number of former smokers returning to smoking.


In the FDA's fantasy world, once the nicotine levels in cigarettes decrease to a "non-addictive" level, smokers will be saved. Last week, the agency announced plans to limit nicotine levels in all cigarettes, even declaring that very low nicotine cigarettes are "appropriate for protecting public health." As pointed out by Dr. Brad Rodu, a medical professor at the University of Louisville, this is a strange endorsement of a deadly product, especially considering that low-nicotine cigarettes in the past have failed to help smokers quit.


Rodu, a contributor to the Tobacco Truth blog, stated, "If the FDA only allows low-nicotine cigarettes, it sets up the perfect black market." The FDA has already banned Juul, which was the only successful cigarette alternative for millions of American adult smokers. These illogical actions will not have any effect on the annual 500,000 smoking-related deaths in the US, or may even lead to an increase in mortality rates.


Currently, the best hope for sensible policy lies outside of the FDA. Perhaps the courts will protect Juul from the FDA's foolish actions, or politicians up for re-election will stand up for voters who enjoy nicotine. However, as long as the FDA and its $800 million tobacco fee remain under the control of anti-nicotine zealots, it will continue to harm the health of Americans.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.